Advertisement

Psychopharmacologic Considerations in Early Childhood

  • Julianna Finelli
  • Mary Margaret GleasonEmail author
Chapter

Abstract

This chapter provides guidelines for the consideration of medication treatment in very young children. It describes the careful assessment required, as well as the need to consider factors affecting the clinical context including access to care, rapid development, parent, child, and clinician attributes, and the limited evidence base. Prescribing practices and the evidence base to date for both pharmacologic and nonpharmacologic interventions are briefly reviewed. Diagnosis-Specific Approaches and Treatment Recommendations for Attention-Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Anxiety, Posttraumatic Stress Disorder, Disorder of Dysregulated Anger and Aggression, Depression and Mood Problems, and Sleep Problems are Included.

Keywords

Preschool psychopharmacology Evidence-based interventions Medications Prescribing practices 

References

  1. AACAP. (2016). Autism spectrum disorders parents medication guide. Washington, DC: AACP.Google Scholar
  2. AAP. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics.  https://doi.org/10.1542/peds.2011-2654
  3. AAP Committee on Drugs. (2002). Uses of drugs not described in the package insert (off-label uses). Pediatrics, 110, 181–182.CrossRefGoogle Scholar
  4. Abikoff, H. B., Thompson, M., Laver-Bradbury, C., Long, N., Forehand, R. L., Miller Brotman, L., et al. (2015). Parent training for preschool ADHD: A randomized controlled trial of specialized and generic programs. Journal of Child Psychology and Psychiatry, 56, 618–631.PubMedCrossRefPubMedCentralGoogle Scholar
  5. APA. (2013). Diagnostic and Statistical Manual of Mental Disorders 5. Washington, DC: American Psychiatric Press.Google Scholar
  6. Arnold, L. E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1443–1450.  https://doi.org/10.1097/00004583-200312000-00011CrossRefPubMedPubMedCentralGoogle Scholar
  7. Assael, B. M. (1999). Therapeutic orphans. European Perspective Pediatrics, 104, 591–592.  https://doi.org/10.1542/peds.104.3.S1.591CrossRefPubMedPubMedCentralGoogle Scholar
  8. Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveillance Summaries, 67(SS-6), 1–23.PubMedCentralCrossRefGoogle Scholar
  9. Barclay, R. P., Penfold, R. B., Sullivan, D., Boydston, L., Wignall, J., & Hilt, R. J. (2017). Decrease in statewide antipsychotic prescribing after implementation of child and adolescent psychiatry consultation services. Health Services Research, 52, 561–578.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Barterian, J. A., Rappuhn, E., Seif, E. L., Watson, G., Ham, H., & Carlson, J. S. (2014). Current state of evidence for medication treatment of preschool internalizing disorders. The Scientific World Journal, 2014, Article ID 286085.CrossRefGoogle Scholar
  11. Berger-Jenkins, E., McKay, M., Newcorn, J., Bannon, W., & Laraque, D. (2012). Parent medication concerns predict underutilization of mental health services for minority children with ADHD. Clinical Pediatrics (Phila), 51, 65–76.CrossRefGoogle Scholar
  12. Biederman, J., Mick, E., Hammerness, P., Harpold, T., Aleardi, M., Dougherty, M., et al. (2005). Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biological Psychiatry, 58, 589.PubMedCrossRefPubMedCentralGoogle Scholar
  13. Birmaher, B., Brent, D. A., Chiappetta, L., Bridge, J., Monga, S., & Baugher, M. (1999). Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A replication study. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1230–1236.PubMedCrossRefPubMedCentralGoogle Scholar
  14. Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. JAMA, 297, 1683–1696.  https://doi.org/10.1001/jama.297.15.1683CrossRefPubMedPubMedCentralGoogle Scholar
  15. Briggs-Gowan, M., & Carter, A. S. (2002). Brief Infant Toddler Social Emotional Assessment (BITSEA) Manual Version 2.0. New Haven, CT: Yale University.Google Scholar
  16. Bufferd, S. J., Dougherty, L. R., Carlson, G. A., & Klein, D. N. (2011). Parent-reported mental health in preschoolers: Findings using a diagnostic interview. Comprehensive Psychiatry, 52, 359–369.PubMedCrossRefPubMedCentralGoogle Scholar
  17. Bussing, R., Koro-Ljungberg, M. E., Gary, F., Mason, D. M., & Garvan, C. W. (2005). Exploring help-seeking for ADHD symptoms: A mixed-methods approach. Harvard Review of Psychiatry, 13, 85–101.PubMedCrossRefPubMedCentralGoogle Scholar
  18. Bussing, R., Schoenberg, N. E., Rogers, K. M., Zima, B. T., & Angus, S. (1998). Explanatory models of ADHD: Do they differ by ethnicity, child gender, or treatment status? Journal of Emotional & Behavioral Disorders, 6, 233.CrossRefGoogle Scholar
  19. Carpenter, A. L., Puliafico, A. C., Kurtz, S. M., Pincus, D. B., & Comer, J. S. (2014). Extending parent–child interaction therapy for early childhood internalizing problems: New advances for an overlooked population. Clinical Child and Family Psychology Review, 17, 340.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Cesena M, Gonzalez-Heydrich J, Szigethy E, ., Kohlenberg TM, DeMaso DR (2000) A case series of eight aggressive young children treated with risperidone. Journal of Child and Adolescent Psychopharmacology 12:337–345.CrossRefGoogle Scholar
  21. Charach, A., Dashti, B., Carson, P., Booker, L., Lim, C. G., Lillie, E., et al. (2012). Attention deficit hyperactivity disorder: Effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment. York: Centre for Reviews and Dissemination.Google Scholar
  22. Chirdkiatgumchai, V., Xiao, H., Fredstrom, B. K., Adams, R. E., Epstein, J. N., Shah, S. S., et al. (2013). National trends in psychotropic medication use in young children: 1994–2009. Pediatrics, 132, 615–623.  https://doi.org/10.1542/peds.2013-1546CrossRefPubMedPubMedCentralGoogle Scholar
  23. Choate, M. L., Pincus, D. B., & Eyberg, S. M. (2005). Parent-child interaction therapy for treatment of separation anxiety disorder in young children: A pilot study. Cognitive and Behavioral Therapy, 12, 136–145.Google Scholar
  24. Choi, Y. K., Moran-Gates, T., Gardner, M. P., & Tarazi, F. I. (2010). Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats. European Neuropsychopharmacology, 20, 187–194.PubMedCrossRefPubMedCentralGoogle Scholar
  25. Christensen, D. L., Bilder, D. A., Zahorodny, W., Pettygrove, S., Durkin, M. S., Fitzgerald, R. T., et al. (2016). Prevalence and characteristics of autism spectrum disorder among 4-year-old children in the autism and developmental disabilities monitoring network. Journal of Developmental and Behavioral Pediatrics, 37, 1–8.  https://doi.org/10.1097/DBP.0000000000000235CrossRefPubMedPubMedCentralGoogle Scholar
  26. Chubinsky, P., & Rappaport, N. (2006). Medication and the fragile alliance: The complex meanings of psychotropic medication to children, adolescents, and families. Journal of Infant, Child, and Adolescent Psychotherapy, 5, 111–123.Google Scholar
  27. Coates, S., & Gaensbauer, T. J. (2009). Event trauma in early childhood: Symptoms, assessment, intervention. Child and Adolescent Psychiatric Clinics, 18, 611–626.CrossRefGoogle Scholar
  28. Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 393.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Cohen, J. A., Mannarino, A. P., Perel, J., & Staron, V. (2007). A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 811–819.PubMedCrossRefPubMedCentralGoogle Scholar
  30. Comer, J. S., Puliafico, A. C., Aschenbrand, S. G., McKnight, K., Robin, J. A., Goldfine, M. E., et al. (2012). A pilot feasibility evaluation of the CALM Program for anxiety disorders in early childhood. Journal of Anxiety Disorders, 26, 40–49.  https://doi.org/10.1016/j.janxdis.2011.08.011PubMedCrossRefPubMedCentralGoogle Scholar
  31. Connor, D. F., Fletcher, K. E., & Swanson, J. M. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 1551–1559.PubMedCrossRefPubMedCentralGoogle Scholar
  32. Copeland, W. E., Angold, A., Costello, E. J., & Egger, H. (2013). Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. The American Journal of Psychiatry, 170, 173–179.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Coşkun, M., Öztürk, M., & Zoroğlu, S. (2012). Escitalopram treatment in preschool children with anxiety disorders: A case series. Bulletin of Clinical Psychopharmacology, 22, 262–267.CrossRefGoogle Scholar
  34. Coskun, M., & Zoroglu, S. (2009). Efficacy and safety of fluoxetine in preschool children with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 19, 297–300.  https://doi.org/10.1089/cap.2008.055CrossRefPubMedPubMedCentralGoogle Scholar
  35. Costello, E. J., Farmer, E. M., Angold, A., Burns, B. J., & Erkanli, A. (1997). Psychiatric disorders among American Indian and white youth in Appalachia: The Great Smoky Mountains Study. American Journal of Public Health, 87, 827–832.  https://doi.org/10.2105/ajph.87.5.827CrossRefPubMedPubMedCentralGoogle Scholar
  36. Danielson, M. L., Visser, S. N., Gleason, M. M., Peacock, G., Claussen, A. H., & Blumberg, S. J. (2017). A national profile of attention-deficit hyperactivity disorder diagnosis and treatment among US children aged 2 to 5 years. Journal of Developmental and Behavioral Pediatrics, 38, 455–464.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Donovan, C. L., & March, S. (2014). Online CBT for preschool anxiety disorders: A randomised control trial. Behaviour Research and Therapy, 58, 24–35.PubMedCrossRefPubMedCentralGoogle Scholar
  38. dosreis, S., Tai, M.-H., Goffman, D., Lynch, S. E., Reeves, G. M., & Shaw, T. (2014). Age-related trends in psychotropic medication use among very young children in foster care. Psychiatric Services, 65, 1452–1457.PubMedCrossRefPubMedCentralGoogle Scholar
  39. dosReis, S., Yoon, Y., Rubin, D. M., Riddle, M. A., Noll, E., & Rothbard, A. (2011). Antipsychotic treatment among youth in foster care. Pediatrics, 128, e1459–e1466.  https://doi.org/10.1542/peds.2010-2970CrossRefPubMedPubMedCentralGoogle Scholar
  40. dosreis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Helath, 91, 1094–1099.CrossRefGoogle Scholar
  41. Dozier, M., Peloso, E., Lewis, E., Laurenceau, J. P., & Levine, S. (2008). Effects of an attachment-based intervention on the cortisol production of infants and toddlers in foster care. Development and Psychopathology, 20, 833–849.CrossRefGoogle Scholar
  42. Dummit, E. S., Klein, R. G., Asche, B., Martin, J., & Tancer, N. K. (1996). Fluoxetine treatment of children with selective mutism: An open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 615–621.PubMedCrossRefPubMedCentralGoogle Scholar
  43. Egger, H. L. (2010). A perilous disconnect: Antipsychotic drug use in very young children. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 3–6.PubMedPubMedCentralGoogle Scholar
  44. Egger, H. L., & Angold, A. (2006). Common emotional and behavioral disorders in preschool children: Presentation, nosology, and epidemiology. Journal of Child Psychology and Psychiatry, 47, 313–337.PubMedCrossRefGoogle Scholar
  45. Ercan, E. S., Basay, B. K., Basay, O., Durak, S., & Ozbaran, B. (2011). Risperidone in the treatment of conduct disorder in preschool children without intellectual disability. Child and Adolescent Psychiatry and Mental Health, 5.  https://doi.org/10.1186/1753-2000-5-10
  46. Ercan, E. S., Kandulu, R., & Akyol Ardic, U. (2012). Preschool children with obsessive-compulsive disorder and fluoxetine treatment. European Child & Adolescent Psychiatry, 21, 169–172.  https://doi.org/10.1007/s00787-012-0244-2CrossRefGoogle Scholar
  47. Eyberg, S. M., Nelson, M. M., & Boggs, S. R. (2008). Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. Journal of Clinical Child and Adolescent Psychology, 37, 215.PubMedCrossRefPubMedCentralGoogle Scholar
  48. Eyberg, S. M., & Pincus, D. (1999). Eyberg Child Behavior Inventory & Sutter-Eyberg Student Behavior Inventory – Revised volume. Odessa, FL: Psychological Assessment Resources.Google Scholar
  49. Fallucco, E. M., Wysocki, T., James, L., Kozikowski, C., Williams, A., & Gleason, M. M. (2017). The brief early childhood screening assessment: Preliminary validity in pediatric primary care. Journal of Developmental and Behavioral Pediatrics, 38, 89–98.PubMedPubMedCentralGoogle Scholar
  50. Faraone, S. V., Biederman, J., & Roe, C. (2002). Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Clinical Psychopharmacology, 22, 468–473.PubMedCrossRefPubMedCentralGoogle Scholar
  51. Fardoulys, C., & Coyne, J. (2016). Circle of security intervention for parents of children with autism spectrum disorder. Australian and New Zealand Journal of Family Therapy, 37, 572–584.CrossRefGoogle Scholar
  52. Fiks, A. G., Mayne, S., DeBartolo, E., Power, T. J., & Guevara, J. P. (2013). Parental preferences and goals regarding ADHD treatment. Pediatrics.  https://doi.org/10.1542/peds.2013-0152
  53. Food and Drug Administration. (2002). Best pharmaceuticals for children act. Silver Spring, MD: FDA.Google Scholar
  54. Franz, L., Angold, A., Copeland, W., Costello, E. J., Towe-Goodman, N., & Egger, H. (2013). Preschool anxiety disorders in pediatric primary care: Prevalence and comorbidity. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 1294–1303. e1291.PubMedPubMedCentralCrossRefGoogle Scholar
  55. Freeman, J., Sapyta, J., Garcia, A., Compton, S., Khanna, M., Flessner, C., et al. (2014). Family-based treatment of early childhood obsessive-compulsive disorder: The pediatric obsessive-compulsive disorder treatment study for young children (POTS Jr)—A randomized clinical trial. JAMA Psychiatry, 71, 689–698.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Garfield, L. D., Brown, D. S., Allaire, B. T., Ross, R. E., Nicol, G. E., & Raghavan, R. (2015). Psychotropic drug use among preschool children in the medicaid program from 36 states. American Journal of Public Health, 105, 524–529.  https://doi.org/10.2105/ajph.2014.302258CrossRefPubMedPubMedCentralGoogle Scholar
  57. Gleason, M. M., Dickstein, S., & Zeanah, C. H. (2010). Recognizing young children in need of mental health assessment: Development and preliminary validity of the Early Childhood Screening Assessment. Infant Mental Health Journal, 31, 1–22.CrossRefGoogle Scholar
  58. Gleason, M. M., Egger, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., et al. (2007). Psychopharmacological treatment for very young children: Contexts and guidelines. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1532–1572.PubMedCrossRefPubMedCentralGoogle Scholar
  59. Gleason, M. M., Goldson, E., Yogman, M. W., & Committee on Psychosocial Aspects of the Child. (2016a). Addressing early childhood emotional and behavioral problems (policy statement). Pediatrics, 138, e20163025.PubMedCrossRefPubMedCentralGoogle Scholar
  60. Gleason, M. M., Goldson, E., Yogman, M. W., & Committee on Psychosocial Aspects of the Child. (2016b). Addressing early childhood emotional and behavioral problems: Technical report. Pediatrics, 138, e20163025.PubMedCrossRefPubMedCentralGoogle Scholar
  61. Gleason, M. M. T., & Lauren, A. (2016). Updates on preschool psychopharmacological treatments. In J. Luby (Ed.), Handbook of preschool mental health. New York, NY: Guilford.Google Scholar
  62. Greenhill, L. (1998a). The use of psychoactive medications in preschoolers: Indications, safety and efficacy. Canadian Journal of Psychiatry, 43, 576–581.PubMedCrossRefPubMedCentralGoogle Scholar
  63. Greenhill, L., Kollins, S., Abikoff, H., McCracken, J., Riddle, M., Swanson, J., et al. (2006). Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1284–1293.PubMedCrossRefPubMedCentralGoogle Scholar
  64. Greenhill, L., Swanson, J., Vitiello, B., Davies, M., Clevenger, W., Wu, M., et al. (2001). Impairment and deportment responses to different methylphenidate doses in children with ADHD: The MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 180–192.PubMedCrossRefPubMedCentralGoogle Scholar
  65. Greenhill, L. L. (1998b). The use of psychotropic medication in preschoolers: Indications, safety and efficacy. Canadian Journal of Psychiatry, 43, 576–581.PubMedCrossRefPubMedCentralGoogle Scholar
  66. Grzeskowiak, L. E., Morrison, J. L., Henriksen, T. B., Bech, B. H., Obel, C., Olsen, J., & Pedersen, L. H. (2016). Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort. BJOG: An International Journal of Obstetrics & Gynaecology, 123(12), 1919–1928.Google Scholar
  67. Harmon, R. J., & Riggs, P. D. (1996). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–1249.  https://doi.org/10.1097/00004583-199609000-00022CrossRefPubMedPubMedCentralGoogle Scholar
  68. Harmon, R. J., & Riggs, P. D. (1999). Clonidine for posttraumatic stress disorder in preschool children. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1247–1249.CrossRefGoogle Scholar
  69. Harvey, B., & Milne, M. (1998). Pharmacotherapy of selective mutism: Two case studies of severe entrenched mutism responsive to adjunctive treatment with fluoxetine. Southern African Journal of Child and Adolescent Mental Health, 10, 59–66.CrossRefGoogle Scholar
  70. Healthy Start Association. (2013). Retrieved March 19, 2018, from http://www.nationalhealthystart.org/healthy_start_initiative/project_directory. Accessed March
  71. Hirota, T., Schwartz, S., & Correll, C. U. (2014). Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy. Journal of the American Academy of Child and Adolescent Psychiatry, 53, 153–173.PubMedCrossRefPubMedCentralGoogle Scholar
  72. Hirshfeld-Becker, D. R., Masek, B., Henin, A., Blakely, L. R., Pollock-Wurman, R. A., McQuade, J., et al. (2010). Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: A randomized clinical trial. Journal of Consulting and Clinical Psychology, 78, 498–510.PubMedCrossRefPubMedCentralGoogle Scholar
  73. Hoffman, K. T., Marvin, R. S., Cooper, G., & Powell, B. (2006). Changing toddlers’ and preschoolers’ attachment classifications: The circle of security intervention. Journal of Consulting and Clinical Psychology, 74, 1017.PubMedCrossRefPubMedCentralGoogle Scholar
  74. Hood, K. K., & Eyberg, S. M. (2003). Outcomes of Parent-Child Interaction Therapy: Mothers’ Reports of Maintenance Three to Six Years After Treatment. Journal of Clinical Child and Adolescent Psychology, 32, 419–430.PubMedCrossRefPubMedCentralGoogle Scholar
  75. Ingrassia, A., & Turk, J. (2005). The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders. European Child & Adolescent Psychiatry, 14, 34–40.CrossRefGoogle Scholar
  76. Kazdin, A. E. (2005). Parent management training: Treatment for oppositional, aggressive, and antisocial behavior in children and adolescents. New York, NY: Oxford University Press.Google Scholar
  77. Kowatch, R. A., Scheffer, R. E., Monroe, E., Delgado, S., Altaye, M., & Lagory, D. (2015). Placebo-controlled trial of valproic acid versus risperidone in children 3–7 years of age with bipolar I disorder. Journal of Child and Adolescent Psychopharmacology, 25, 306–313.PubMedPubMedCentralCrossRefGoogle Scholar
  78. Kratochvil, C. J., Egger, H., Greenhill, L. L., & McGough, J. J. (2006). Pharmacological management of preschool ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 115–118.PubMedCrossRefPubMedCentralGoogle Scholar
  79. Kratochvil, C. J., Vaughan, B. S., Mayfield-Jorgensen, M. L., March, J. S., Kollins, S. H., Murray, D. W., et al. (2007). A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17, 175–185.PubMedCrossRefPubMedCentralGoogle Scholar
  80. Kratochvil, C. J., Vaughan, B. S., Stoner, J. A., Daughton, J. M., Lubberstedt, B. D., Murray, D. W., et al. (2011). A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics, 127, e862–e868.  https://doi.org/10.1542/peds.2010-0825CrossRefPubMedPubMedCentralGoogle Scholar
  81. Lawton, K. E., Gerdes, A. C., Haack, L. M., & Schneider, B. (2014). Acculturation, cultural values, and latino parental beliefs about the etiology of ADHD. Administration and Policy in Mental Health and Mental Health Services Research, 41, 189–204.  https://doi.org/10.1007/s10488-012-0447-3CrossRefPubMedPubMedCentralGoogle Scholar
  82. Lee, C. S., Williamson, L. R., Martin, S. E., DeMarco, M., Majczak, M., Martini, J., et al. (2015). Adverse events in very young children prescribed psychotropic medications: preliminary findings from an acute clinical sample. Journal of Child and Adolescent Psychopharmacology, 25, 509–513.  https://doi.org/10.1089/cap.2015.0034CrossRefPubMedPubMedCentralGoogle Scholar
  83. Lee, S. S., Lahey, B. B., Owens, E. B., & Hinshaw, S. P. (2008). Few preschool boys and girls with ADHD are well-adjusted during adolescence. Journal of Abnormal Child Psychology, 36, 373–383.  https://doi.org/10.1007/s10802-007-9184-6CrossRefPubMedPubMedCentralGoogle Scholar
  84. Licis, A. (2017). Sleep disorders: Assessment and treatment in preschool-aged children. Child and Adolescent Psychiatric Clinics, 26, 587–595.CrossRefGoogle Scholar
  85. Lieberman, A. F., Van Horn, P. J., & Ippen, C. G. (2005). Toward evidence-based treatment: Child-parent psychotherapy with preschoolers exposed to marital violence. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 1241–11248.CrossRefGoogle Scholar
  86. Luby, J., Mrakotsky, C., Stalets, M. M., Belden, A., Heffelfinger, A., Williams, M., et al. (2006). Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy. Journal of Child and Adolescent Psychopharmacology, 16, 575–587.  https://doi.org/10.1089/cap.2006.16.575CrossRefPubMedPubMedCentralGoogle Scholar
  87. Luby, J. L., & Belden, A. (2006). Defining and validating bipolar disorder in the preschool period. Development and Psychopathology, 18, 971–988.PubMedCrossRefPubMedCentralGoogle Scholar
  88. Luby, J. L., Heffelfinger, A., Koenig-McNaught, A. L., Brown, K., & Spitznagel, E. (2004). The preschool feelings checklist: A brief and sensitive screening measure for depression in young children. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 708–716.PubMedCrossRefPubMedCentralGoogle Scholar
  89. Luby, J. L., Lenze, S., & Tillman, R. (2011). A novel early intervention for preschool depression: Findings from a pilot randomized controlled trial. Journal of Child Psychology and Psychiatry, 53, 315–322.  https://doi.org/10.1111/j.1469-7610.2011.02483.xCrossRefGoogle Scholar
  90. Magnusson, D. M., Minkovitz, C. S., Kuhlthau, K. A., Caballero, T. M., & Mistry, K. B. (2017). Beliefs regarding development and early intervention among low-income African American and Hispanic mothers. Pediatrics, 140.  https://doi.org/10.1542/peds.2017-2059
  91. Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, e441–e448.  https://doi.org/10.1542/peds.2007-0984CrossRefPubMedPubMedCentralGoogle Scholar
  92. Maniadaki, K., Sonuga-Barke, E., Kakouros, E., & Karaba, R. (2007). Parental beliefs about the nature of ADHD behaviours and their relationship to referral intentions in preschool children. Child: Care, Health and Development, 33, 188–195.Google Scholar
  93. Marcus, C. L., Brooks, L. J., Draper, K. A., Gozal, D., Halbower, A. C., Jones, J., et al. (2012). Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics, 130, 576–584.PubMedCrossRefPubMedCentralGoogle Scholar
  94. Masi, G., Cosenza, A., Mucci, M., & Brovedani, P. (2003). A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. Journal of Clinical Psychiatry, 64, 1039–1047.PubMedCrossRefPubMedCentralGoogle Scholar
  95. Masse, J. J., McNeil, C. B., Wagner, S. M., & Chorney, D. B. (2007). Parent-child interaction therapy and high functioning autism: A conceptual overview. Journal of Early and Intensive Behavior Intervention, 4, 714.CrossRefGoogle Scholar
  96. McDonough, S. D. (2000). Interaction guidance: An approach for difficult-to-engage families. In C. H. Zeanah (Ed.), Handbook of infant mental health (2nd ed.). New York, NY: Guilford Press.Google Scholar
  97. McMahon, R. J., & Forehand, R. L. (2005). Helping the noncompliant child: Family-based treatment for oppositional behavior. New York, NY: Guilford Press.Google Scholar
  98. Merenstein, D., Diener-West, M., Halbower, A. C., Krist, A., & Rubin, H. R. (2006). The trial of infant response to diphenhydramine: The tired study—A randomized, controlled, patient-oriented trial. Archives of Pediatrics & Adolescent Medicine, 160, 707–712.  https://doi.org/10.1001/archpedi.160.7.707CrossRefGoogle Scholar
  99. Mezzacappa, A., Lasica, P., Gianfagna, F., Cazas, O., Hardy, P., Falissard, B., et al. (2017). Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: A systematic review and meta-analysis. JAMA Pediatrics, 171, 555–563.  https://doi.org/10.1001/jamapediatrics.2017.0124CrossRefPubMedPubMedCentralGoogle Scholar
  100. Mindell, J. A., Kuhn, B., Lewin, D. S., Meltzer, L. J., & Sadeh, A. (2006). Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep, 29, 1263–1276.PubMedPubMedCentralGoogle Scholar
  101. Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001). Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters. Journal of Child and Adolescent Psychopharmacology, 11, 15–24.  https://doi.org/10.1089/104454601750143366CrossRefPubMedPubMedCentralGoogle Scholar
  102. Morgan, P. L., Staff, J., Hillemeier, M. M., Farkas, G., & Maczuga, S. (2013). Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade. Pediatrics, 132, 85–93.  https://doi.org/10.1542/peds.2012-2390CrossRefPubMedPubMedCentralGoogle Scholar
  103. Morgenthaler, T. I., Owens, J., Alessi, C., Boehlecke, B., Brown, T. M., Coleman Jr., J., et al. (2006). Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep, 29, 1277–1281.PubMedCrossRefPubMedCentralGoogle Scholar
  104. Murphy, J. M., Ichinose, C., Hicks, R. C., Kingdon, D., Crist-Whitzel, J., Jordan, P., et al. (1996). Utility of the pediatric symptom checklist as a psychosocial screen to meet the federal early and periodic screening, diagnosis, and treatment (EPSDT) standards: A pilot study. The Journal of Pediatrics, 129, 864.PubMedCrossRefPubMedCentralGoogle Scholar
  105. Nagaraj, R., Singhi, P., & Malhi, P. (2006). Risperidone in children with autism: Randomized, placebo-controlled, double-blind study. Journal of Child Neurology, 21, 450.PubMedCrossRefGoogle Scholar
  106. Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 13–23.PubMedGoogle Scholar
  107. Olfson, M., King, M., & Schoenbaum, M. (2016). Stimulant treatment of young people in the United States. Journal of Child and Adolescent Psychopharmacology, 26, 520–526.PubMedPubMedCentralCrossRefGoogle Scholar
  108. Oner, O., & Oner, P. (2008). Psychopharmacology of pediatric obsessive-compulsive disorder: Three case reports. Journal of Psychopharmacology, 22, 809–811.  https://doi.org/10.1177/0269881107083362CrossRefPubMedGoogle Scholar
  109. Owens, J. A., Babcock, D., Blumer, J., Chervin, R., Ferber, R., Goetting, M., et al. (2006). The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: Rational approaches. A consensus meeting summary. Journal of Clinical Sleep Medicine, 1, 49–59.Google Scholar
  110. Paul, I. M., Yoder, K. E., Crowell, K. R., Shaffer, M. L., McMillan, H. S., Carlson, L. C., et al. (2004). Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics, 114, e85–e90.  https://doi.org/10.1542/peds.114.1.e85CrossRefPubMedPubMedCentralGoogle Scholar
  111. Pavuluri, M. N., Henry, D. B., Carbray, J. A., Sampson, G. A., Naylor, M. W., & Janicak, P. G. (2006). A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 16, 336–350.PubMedCrossRefPubMedCentralGoogle Scholar
  112. Pavuluri, M. N., Janicak, P. G., & Carbray, J. A. (2002). Topirimate plus risperidone for controlling weight gain and symptoms in preschool mania. Journal of Child and Adolescent Psychopharmacology, 12, 271–273.PubMedCrossRefPubMedCentralGoogle Scholar
  113. Pennap, D., Burcu, M., Safer, D. J., & Zito, J. M. (2017). The impact of a state medicaid peer-review authorization program on pediatric use of antipsychotic medications. Psychiatric Services, 69(3), 293–299.PubMedCrossRefPubMedCentralGoogle Scholar
  114. Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., & Wozniak, J. R. (1996). Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: A systematic chart review of 62 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 599–605.  https://doi.org/10.1097/00004583-199605000-00014CrossRefPubMedPubMedCentralGoogle Scholar
  115. Rabbani, A., & Alexander, G. C. (2009). Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorder. Health Services Research, 44, 2060–2078.PubMedPubMedCentralCrossRefGoogle Scholar
  116. Rachmiel, M., Johnson, T., & Daneman, D. (2006). Clonidine ingestion in children is not uneventful. The Journal of Pediatrics, 148, 850.PubMedCrossRefPubMedCentralGoogle Scholar
  117. Robb, A. S., Cueva, J. E., Sporn, J., Yang, R., & Vanderburg, D. G. (2010). Sertraline treatment of children and adolescents with posttraumatic stress disorder: A double-blind, placebo-controlled trial. Journal of Child and Adolescent Psychopharmacology, 20, 463–471.PubMedCrossRefPubMedCentralGoogle Scholar
  118. RUPP. (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Archives of General Psychiatry, 62, 1266–1174.CrossRefGoogle Scholar
  119. Russo, R. M., Gurara, V. J., & Allen, J. E. (1976). The effectiveness of diphenhydramine HCl in pediatric sleep disorders. Journal of Clinical Pharmacology, 16, 284–288.PubMedCrossRefPubMedCentralGoogle Scholar
  120. Sanders, M. R., Baker, S., & Turner, K. M. T. (2012). A randomized controlled trial evaluating the efficacy of Triple P online with parents of children with early-onset conduct problems. Behaviour Research and Therapy, 50, 675–684.  https://doi.org/10.1016/j.brat.2012.07.004PubMedCrossRefPubMedCentralGoogle Scholar
  121. Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., et al. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. The American Journal of Psychiatry, 158, 1067–1074.  https://doi.org/10.1176/appi.ajp.158.7.1067CrossRefPubMedPubMedCentralGoogle Scholar
  122. Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–852.  https://doi.org/10.1097/00004583-199706000-00023CrossRefPubMedPubMedCentralGoogle Scholar
  123. Scheeringa MS (2002) Young child PTSD checklist. Retrieved January 4, 2017, from http://www.infantinstitute.org/MikeSPDF/YCPC_Aug2012.pdf. Accessed March 17 2018
  124. Scheeringa, M. S., Salloum, A., Arnberger, R. A., Weems, C. F., Amaya-Jackson, L., & Cohen, J. A. (2007). Feasibility and effectiveness of cognitive-behavioral therapy for posttraumatic stress disorder in preschool children: Two case reports. Journal of Traumatic Stress, 20, 631–636.PubMedCrossRefPubMedCentralGoogle Scholar
  125. Scheeringa, M. S., Weems, C. F., Cohen, J. A., Amaya-Jackson, L., & Guthrie, D. (2011). Trauma focused cognitive-behavioral treatment for posttraumatic stress disorder in three through six year-old children: A randomized clinical trial. Journal of Child Psychology and Psychiatry, 52, 853.PubMedCrossRefPubMedCentralGoogle Scholar
  126. Scheffer, R. E., & Niskala, A. J. A. (2004). The diagnosis of preschool bipolar disorder presenting with mania: Open pharmacological treatment. Journal of Affective Disorders, 82, S25–S34.PubMedCrossRefPubMedCentralGoogle Scholar
  127. Sheldrick, R. C., Henson, B. S., Merchant, S., Neger, E. N., Murphy, J. M., & Perrin, E. C. (2012). The preschool pediatric symptom checklist (PPSC): Development and initial validation of a new social/emotional screening instrument. Academic Pediatrics, 12, 456–467.  https://doi.org/10.1016/j.acap.2012.06.008PubMedPubMedCentralCrossRefGoogle Scholar
  128. Shonkoff, J. P., & Phillips, D. A. (2000). From neurons to neighborhoods: The science of early childhood development committee on integrating the science of early childhood development. Washington, D.C.: National Academy Press.Google Scholar
  129. Short, E. J., Manos, M. J., Findling, R. L., & Schubel, E. A. (2004). A prospective study of stimulant response in preschool children: insights from ROC analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 251–259.CrossRefGoogle Scholar
  130. Short, E. J., Manos, M. J., Findling, R. L. S., & Emily, A. (2004). A prospective study of stimulant response in preschool children: Insights from ROC analyses. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 251–259.PubMedCrossRefPubMedCentralGoogle Scholar
  131. Smits, M. G., van Stel, H. F., van der Heijden, K., Meijer, A. M., Coenen, A. M. L., & Kerkhof, G. A. (2003). Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: A randomized placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1286–1293.PubMedCrossRefPubMedCentralGoogle Scholar
  132. Spence, S. H., Rapee, R., McDonald, C., & Ingram, M. (2001). The structure of anxiety symptoms among preschoolers. Behaviour Research and Therapy, 39, 1293.PubMedCrossRefPubMedCentralGoogle Scholar
  133. Staller, J. (2007). Psychopharmacologic treatment of aggressive preschoolers: A chart review. Journal of Neuropsychopharmacology and Biological Psychiatry, 31, 131–135.CrossRefGoogle Scholar
  134. Stein, B. D., Leckman-Westin, E., Okeke, E., Scharf, D. M., Sorbero, M., Chen, Q., et al. (2014). The effects of prior authorization policies on medicaid-enrolled children’s use of antipsychotic medications: Evidence from two mid-Atlantic states. Journal of Child and Adolescent Psychopharmacology, 24, 374–381.  https://doi.org/10.1089/cap.2014.0008CrossRefPubMedPubMedCentralGoogle Scholar
  135. Steinsbekk, S., Berg-Nielsen, T. S., & Wichstrøm, L. (2013). Sleep disorders in preschoolers: Prevalence and comorbidity with psychiatric symptoms. Journal of Developmental and Behavioral Pediatrics, 34, 633–641.PubMedCrossRefPubMedCentralGoogle Scholar
  136. Sujan, A. C., Rickert, M. E., Öberg, A., Quinn, P. D., Hernández-Díaz, S., Almqvist, C., et al. (2017). Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit/hyperactivity disorder in offspring. JAMA, 317, 1553–1562.  https://doi.org/10.1001/jama.2017.3413CrossRefPubMedPubMedCentralGoogle Scholar
  137. The MTA Cooperative Group. (1999). A 14 month randomised clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086.CrossRefGoogle Scholar
  138. Van der Heijden, K. B., Smits, M. G., Van Someren, E., Ridderinkhof, K. R., & Gunning, W. B. (2007). Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 233–241.PubMedCrossRefPubMedCentralGoogle Scholar
  139. van der Veen-Mulders, L., van den Hoofdakker, B. J., Nauta, M. H., Emmelkamp, P., & Hoekstra, P. J. (2017). Methylphenidate has superior efficacy over parent–child interaction therapy for preschool children with disruptive behaviors. Journal of Child and Adolescent Psychopharmacology, 28(1), 66–73.PubMedCrossRefPubMedCentralGoogle Scholar
  140. Webster-Stratton, C. (2011). Combining parent and child training for young children with ADHD. Journal of Clinical Child and Adolescent Psychology, 40, 191–203.  https://doi.org/10.1080/15374416.2011.546044CrossRefPubMedPubMedCentralGoogle Scholar
  141. Webster-Stratton, C., Reid, M. J., & Hammond, M. (2004). Treating children with early-onset conduct problems: intervention outcomes for parent, child, and teacher training. Journal of Clinical Child and Adolescent Psychology, 33, 105–124.PubMedCrossRefPubMedCentralGoogle Scholar
  142. Weiss, M. D., Wasdell, M. B., Bomben, M. M., Rea, K. J., & Freeman, R. D. (2006). Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 512–519.PubMedCrossRefPubMedCentralGoogle Scholar
  143. West, L., Brunssen, S. H., & Waldrop, J. (2009). Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors. Journal for Specialists in Pediatric Nursing, 14, 183–191.  https://doi.org/10.1111/j.1744-6155.2009.00196.xCrossRefPubMedPubMedCentralGoogle Scholar
  144. Wichstrøm, L., Berg-Nielsen, T. S., Angold, A., Egger, H. L., Solheim, E., & Sveen, T. H. (2012). Prevalence of psychiatric disorders in preschoolers. Journal of Child Psychology and Psychiatry, 53, 695–705.PubMedCrossRefPubMedCentralGoogle Scholar
  145. Wigal, S. B., Gupta, S., Greenhill, L., Posner, K., Lerner, M., Steinhoff, K., et al. (2007). Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 17, 153–164.PubMedCrossRefPubMedCentralGoogle Scholar
  146. Wigal, T., Greenhill, L., Chuang, S., McGough, J., Vitiello, B., Skrobala, A., et al. (2006). Safety and tolerability of methylphenidate in preschool children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1294–1303.PubMedCrossRefPubMedCentralGoogle Scholar
  147. Yeh, M., Hough, R. L., McCabe, K., Lau, A., & Garland, A. (2004). Parental beliefs about the causes of child problems: Exploring racial/ethnic patterns. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 605–612.PubMedCrossRefPubMedCentralGoogle Scholar
  148. Zero to Three. (2016). Diagnostic classification of mental and developmental disorders in infancy and early childhood (Rev. ed.). Washington, DC: Zero to Three Press.Google Scholar
  149. Zito, J., Safer, D., dosReis, S., Gardner, J., Boles, M., & Lynch, F. (2000a). Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association, 283, 1025–1030.PubMedCrossRefPubMedCentralGoogle Scholar
  150. Zito, J. M., Safer, D. J., DosReis, S., Gardner, J. F., Magder, L., Soeken, K., et al. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17–25.  https://doi.org/10.1001/archpedi.157.1.17CrossRefPubMedPubMedCentralGoogle Scholar
  151. Zito, J. M., Safer, D. J., Valluri, S., Gardner, J. F., Korelitz, J. J., & Mattison, R. E. (2007). Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology, 17, 195–203.PubMedCrossRefPubMedCentralGoogle Scholar
  152. Zito, J. M., Safer, D. J., Zuckerman, I. H., Gardner, J. F., & Soeken, K. L. (2005). Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services, 56, 157–163.PubMedCrossRefPubMedCentralGoogle Scholar
  153. Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Boles, M., & Lynch, F. (2000b). Trends in the prescribing of psychotropic medications to preschoolers. JAMA, 283, 1025–1030.  https://doi.org/10.1001/jama.283.8.1025CrossRefPubMedPubMedCentralGoogle Scholar
  154. Zuckerman, M. L., et al. (2007). Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: A retrospective chart review. Journal of Child and Adolescent Psychopharmacology, 17, 165–174.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Psychiatry and Behavioral Sciences PediatricsTulane University School of MedicineNew OrleansUSA

Personalised recommendations